Researchers aim to improve outcomes for patients with cervical cancer through evidence-based quality metrics tracking.
Cleveland Clinic physicians assessed fertility-sparing procedures for patients with early-stage cervical cancer.
ASTRO 2022 abstracts featured notable research findings for use of radiotherapy in diseases such as early-stage breast cancer, orbital indolent B-cell lymphoma, and locally advanced cervical cancer.
Patients with early cervical cancer have an excellent prognosis and about 40% of them are of reproductive age, making fertility a key concern for them. This article explores the oncologic and reproductive outcomes of fertility sparing procedures for this patient population.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Next generation sequencing provides insights into more effective treatments for a patient’s rare cancer.
From maternal mortality and rising STI rates to trend-reversing increases in mortality from cervical cancer, there are reasons to be concerned about women’s health in the United States. In this article, obstetricians, gynecologists and women’s health specialists discuss research related to the political context of women’s health, and their efforts to improve access to comprehensive women’s health services.
Pelin Batur, MD, Ob/Gyn and Women’s Health Specialist at Cleveland Clinic, reviews cervical screening methods and appropriate follow-up protocol for abnormal results.
Women’s health specialist Pelin Batur, MD, differentiates between three screening algorithms for cervical cancer and shares tips about how to counsel patients about the HPV vaccine.
HPV vaccination can prevent 70% of cervical cancers and 90% of genital warts. Pelin Batur, MD, discusses the latest vaccination timeline and dosing guidelines.
Automated visual evaluation of the cervix may help eradicate cervical cancer in low-resource communities.